8-K//Current report
Ambrx Biopharma Inc. 8-K
Accession 0001193125-23-068506
CIK 0001836056operating
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 8:00 AM ET
Size
223.5 KB
Accession
0001193125-23-068506
Documents
- 8-Kd480452d8k.htmPrimary
8-K
- EX-99.1d480452dex991.htm
EX-99.1
- EX-101.SCHamam-20230313.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.DEFamam-20230313_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
- EX-101.LABamam-20230313_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREamam-20230313_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICg480452g0313052354048.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLd480452d8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-23-068506-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Ambrx Biopharma Cayman, Inc.
CIK 0001836056
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001836056
Filing Metadata
- Form type
- 8-K
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 8:00 AM ET
- Size
- 223.5 KB